UCP2 and colorectal carcinoma: The high amounts of NADPH spent by cells for this metabolic pathway and the parallel decrease in glucose-6-phosphate dehydrogenase activity of Ucp2 KO CRC cells reduced the GSH/GSSG ratio and increased ROS levels.